| scholarly article | Q13442814 |
| P50 | author | Minesh Mehta | Q56533682 |
| Susan M Blaney | Q73565675 | ||
| P2093 | author name string | Children's Oncology Group | |
| Percy Ivy | |||
| Peter C Adamson | |||
| Ian F Pollack | |||
| Joel M Reid | |||
| Mark Krailo | |||
| Matthew M Ames | |||
| Gregory Reaman | |||
| Tianni Zhou | |||
| Gilbert Vezina | |||
| Kristin A Bradley | |||
| P2860 | cites work | Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas. | Q55471181 |
| Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma. | Q55481768 | ||
| In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer | Q73203874 | ||
| Brainstem gliomas | Q79359957 | ||
| A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952 | Q24671734 | ||
| Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase | Q28567883 | ||
| A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities | Q30615083 | ||
| Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases | Q30662282 | ||
| Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points | Q30713105 | ||
| Diffuse brainstem glioma in children: critical review of clinical trials | Q31033307 | ||
| Advances toward an understanding of brainstem gliomas | Q31033870 | ||
| Pediatric brain stem gliomas: an update | Q32055396 | ||
| Pediatric brain stem gliomas: a review | Q32127884 | ||
| Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases | Q35164078 | ||
| Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial | Q35618873 | ||
| Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study | Q36773672 | ||
| UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group | Q36879740 | ||
| Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers | Q40499821 | ||
| Prognostic factors in pediatric brain-stem gliomas | Q41344144 | ||
| Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiforme | Q42647577 | ||
| A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma | Q44374100 | ||
| Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study | Q44483736 | ||
| The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy | Q46221713 | ||
| Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial | Q48232854 | ||
| Hyperfractionated radiotherapy in the management of diffuse intrinsic brainstem tumors: when is enough enough? | Q48245743 | ||
| Trends in reported incidence of primary malignant brain tumors in children in the United States | Q48398308 | ||
| Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d'Oncologie Pédiatrique | Q48637093 | ||
| Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy. | Q49111287 | ||
| Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. | Q54194990 | ||
| P433 | issue | 5 | |
| P921 | main subject | gadolinium | Q1832 |
| adaptive radiation therapy | Q180507 | ||
| P304 | page(s) | 752-758 | |
| P577 | publication date | 2008-08-20 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study | |
| P478 | volume | 10 |
| Q55456554 | Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery. |
| Q92140233 | Childhood brain tumors: current management, biological insights, and future directions |
| Q33970971 | Childhood brain tumors: epidemiology, current management and future directions |
| Q57069047 | Clinical development of photodynamic agents and therapeutic applications |
| Q39380445 | Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy? |
| Q38264309 | Diffuse intrinsic pontine glioma: time for therapeutic optimism |
| Q30452219 | Improving the Radiosensitivity of Radioresistant and Hypoxic Glioblastoma |
| Q59797717 | Intersection of Brain Development and Paediatric Diffuse Midline Gliomas: Potential Role of Microenvironment in Tumour Growth |
| Q48500564 | Motexafin gadolinium: a novel radiosensitizer for brain tumors |
| Q38014582 | Motexafin gadolinium: a promising radiation sensitizer in brain metastasis |
| Q36485991 | Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study |
| Q41592783 | New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis. |
| Q36865982 | Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas |
| Q41109977 | Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma |
| Q47896370 | Radiosensitization of esophageal cancer cells ECA109 by knockdown of H2AX. |
| Q53154556 | Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial. |
| Q43514065 | Specific molecular and cellular events induced by irradiated X-ray photoactivatable drugs raise the problem of co-toxicities: particular consequences for anti-cancer synchrotron therapy |
| Q35343010 | Synthesis and biological evaluation of a class of mitochondrially-targeted gadolinium(III) agents. |
| Q47832897 | T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity |
| Q34115304 | Targeting mitochondria for cancer therapy |
| Q46897880 | Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab. |
| Q64247290 | Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol |
Search more.